Insider · CIK 0001719077
Amit B. Shah
Files at OTLC (Oncotelic Therapeutics, Inc.). First filing Jun 22, 2026, latest Jun 22, 2026.
In brief
Amit B. Shah files SEC Form 4 as CFO at OTLC (Oncotelic Therapeutics, Inc.). Since Jun 22, 2026, Amit B. Shah has reported 1 open-market buy worth $1,000 and 0 open-market sells worth $0, the latest filed on Jun 22, 2026.
A track record needs three past buys with six months of prices behind them; Amit B. Shah has 0, so none is measured yet.
The newest scored trade: bought $1,000 of OTLC on Jun 22, 2026, filed Jun 22, 2026, scored 41 (moderate). In the last 12 months: 1 buy worth $1,000 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OTLC: Oncotelic Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | Oncotelic Therapeutics, Inc. | $1,000 20,000 shares | +6% | +67% from low-55% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | OTLC Oncotelic Therapeutics, Inc. | AGrant or award Restricted stock Unitsderivative | +1,500 | $0.00 | $0 | 1,500 | Jul 14, 2026 |
| Jun 22, 2026 | OTLC Oncotelic Therapeutics, Inc. | POpen-market purchase Common Stock | +20,000 | $0.05 | $1,000 | 378,837 | Jun 22, 2026 |
Questions about Amit B. Shah
Answered from the filings on this page, as of the latest one.
Is Amit B. Shah buying or selling?
In the last 12 months Amit B. Shah reported 1 open-market buy worth $1,000 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $1,000 of OTLC on Jun 22, 2026. Grants, option exercises and tax withholding are not counted.
How did Amit B. Shah's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Amit B. Shah has 0.
Where does Amit B. Shah file Form 4?
Amit B. Shah has filed Form 4 at OTLC (Oncotelic Therapeutics, Inc.) as CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.